Mediconz International Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 128.91%
(FY 2021)
- Profit -48.46%
(FY 2021)
- Ebitda -46.27%
(FY 2021)
- Net Worth 55.41%
(FY 2021)
- Total Assets 89.39%
(FY 2021)
About Mediconz International
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammed Vali and Asma Shaikh serve as directors at the Company.
- CIN/LLPIN
U29220MH2009PTC194424
- Company No.
194424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mediconz International Private Limited offer?
Mediconz International Private Limited offers a wide range of products and services, including Electrical Panels & Distribution Box, Industrial Control Panel, Forceps & Graspers, Surgical Pendant, Surgical & ICU Equipments, Operation Theater Equipments, Hospital and Medical Furniture, Hospital Equipment, Doors and Windows, Sliding Doors.
Who are the key members and board of directors at Mediconz International?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Vali  | Director | 29-Jul-2009 | Current |
| Asma Shaikh | Additional Director | 06-Feb-2012 | Current |
Financial Performance of Mediconz International.
Mediconz International Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 128.91% increase. The company also saw a substantial fall in profitability, with a 48.46% decrease in profit. The company's net worth Soared by an impressive increase of 55.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediconz International?
In 2020, Mediconz International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediconz International?
Unlock and access historical data on people associated with Mediconz International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediconz International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediconz International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
